Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Globus Medical, Inc. before investing.

In this article, we go over a few key elements for understanding Globus Medical, Inc.’s stock price such as:

• Globus Medical, Inc.’s current stock price and volume
• Why Globus Medical, Inc.’s stock price changed recently
• Upgrades and downgrades for GMED from analysts
• GMED’s stock price momentum as measured by its relative strength

About Globus Medical, Inc. (GMED)

Before we jump into Globus Medical, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary nailing, and regenerative biologic products; hip and knee joint solutions, including modular hip stems and acetabular cups for total hip arthroplasty, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants; and neuromonitoring services, which provides onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company also offers enabling technologies, such as imaging, navigation, and robotics (INR) solutions for assisted surgery, which includes the ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures with screw and interbody spacer placement applications; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative, image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cell, tissue, and cellular and tissue-based products. The company sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Want to learn more about Globus Medical, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Globus Medical, Inc..

Globus Medical, Inc.’s Stock Price as of Market Close

As of May 16, 2025, 12:46 PM, CST, Globus Medical, Inc.’s stock price was $60.910.

Globus Medical, Inc. is up 5.34% from its previous closing price of $57.820.

During the last market session, Globus Medical, Inc.’s stock traded between $58.270 and $61.120. Currently, there are approximately 136.76 million shares outstanding for Globus Medical, Inc..

Globus Medical, Inc.’s price-earnings (P/E) ratio is currently at 43.3, which is high compared to the Health Care Equipment & Supplies industry median of 34. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Globus Medical, Inc. Stock Price History

Globus Medical, Inc.’s (GMED) price is currently down 15.13% so far this month.

During the month of May, Globus Medical, Inc.’s stock price has reached a high of $73.050 and a low of $54.480.

Over the last year, Globus Medical, Inc. has hit prices as high as $94.930 and as low as $54.480. Year to date, Globus Medical, Inc.’s stock is down 26.36%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Globus Medical, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of May 15, 2025, there were 10 analysts who downgraded Globus Medical, Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Globus Medical, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Globus Medical, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Globus Medical, Inc.’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Globus Medical, Inc. (GMED) by visiting AAII Stock Evaluator.

Relative Price Strength of Globus Medical, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of May 15, 2025, Globus Medical, Inc. has a weighted four-quarter relative price strength of -8.63%, which translates to a Momentum Score of 30 and is considered to be Weak.

Want to learn more about how Globus Medical, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Globus Medical, Inc. Stock Price: Bottom Line

As of May 16, 2025, Globus Medical, Inc.’s stock price is $60.910, which is up 5.34% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Globus Medical, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.